Evidence map›Paper›PMID 40449554›Full record

ArticleJournal of the National Cancer Institute2025

Sexual health outcomes after colorectal cancer diagnosis in females: a population-based cohort study.

Niki Oveisi, Eric C Sayre, Lori A Brotto, Vicki Cheng, Vienna Cheng, Sharlene Gill, Gillian E Hanley, Helen McTaggart-Cowan, Stuart Peacock, Meera Rayar and 4 more

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Niki OveisiFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-5688-6125
Eric C SayreBritish Columbia Centre on Substance Use, Vancouver, BC, Canada.ORCID 0000-0002-4526-278X
Lori A BrottoFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-7552-8588
Vicki ChengFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-5030-9135
Vienna ChengFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID 0009-0009-7053-559X
Sharlene GillFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-3306-3617
Gillian E HanleyFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-9594-0545
Helen McTaggart-CowanBC Cancer, Vancouver, BC, Canada.
Stuart PeacockBC Cancer, Vancouver, BC, Canada.ORCID 0000-0002-8243-8721
Meera RayarFaculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Amirrtha SrikanthanFaculty of Medicine, University of Ottawa, Ottawa, ON, Canada.ORCID 0000-0002-8903-0040
Dani TaylorPatient Research Partner.
Mikaela BarnesPatient Research Partner.ORCID 0009-0006-3591-199X
Mary A De VeraFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-2205-2683

Funding

CIHR EDC-186610CIHR PJT-159467Social Sciences and Humanities Research Council 767-2021-2468
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) affects a growing number of females. Our objective was to evaluate the impact of CRC on sexual health outcomes among females, while controlling for age.

methodsWe conducted a cohort study using administrative health data from the province of British Columbia (BC) including linked health visits and cancer registry from 1985 to 2017. The cohort included females with CRC (n = 25 402; mean age [SD]: 69.0 [13.1]) and matched controls without CRC (n = 254 020; 69.0 [13.1]) in a 1:10 ratio by age, further stratified by age groups (≤39 years and ≥40 years). Multivariable Cox regression models assessed the associations between CRC and 5 sexual health outcomes (dyspareunia, pelvic inflammatory disease, endometriosis, abnormal bleeding, and premature ovarian failure), adjusting for covariates. Sensitivity analyses focused on females with CRC to explore associations between sociodemographic and cancer-related factors and sexual health outcomes. Tests were 2-sided (statistical significance P <.05).

resultsFemales with CRC had higher risks of dyspareunia (HR 1.67; 95% CI = 1.62 to 1.73), pelvic inflammatory disease (HR 3.42; 95% CI = 3.07 to 3.81), and endometriosis (HR 1.95; 95% CI = 1.69 to 2.25) compared to controls. In the ≥40-year group, these associations persisted, while in the ≤39-year group, endometriosis was not associated with CRC, but premature ovarian failure was (HR 1.75; 95% CI = 1.40 to 2.19). In sensitivity analyses, we also observed associations with cancer treatments (surgery, chemotherapy, radiation) and sexual health outcomes.

conclusionsThis population-based study identified associations between CRC and adverse sexual health outcomes among female patients, highlighting the need for targeted interventions and support.

Indexed as

Colorectal NeoplasmsSexual HealthAdultAgedBritish ColumbiaCase-Control StudiesCohort StudiesDyspareuniaEndometriosisFemaleHumansMiddle AgedPelvic Inflammatory DiseaseRegistries

Identifiers

PMID40449554
PMCPMC12415961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.